Clinical Investigation of the Clareon® Intraocular Lens (IOL)

Completed · Not applicable

Conditions studied: Cataract

In brief

The objective of this study is to compare visual acuity and adverse event outcomes from the Clareon intraocular lens (IOL) to historical safety and performance endpoint (SPE) rates.

Key facts

Study ID

NCT03170154

Run by

Alcon Research

People needed

376

Starts

2017-07-25

Expected to finish

2019-02-15

Last updated by the study team

2020-08-03

Who can join

Age: 22 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Alcon Investigative Site — Fresno, California, United States
• Alcon Investigative Site — Sacramento, California, United States
• Alcon Investigative Site — San Leandro, California, United States
• Alcon Investigative Site — Deerfield Beach, Florida, United States
• Alcon Investigative Site — Orland Park, Illinois, United States
• Alcon Investigative Site — Bloomfield Hills, Michigan, United States
• Alcon Investigative Site — Kansas City, Missouri, United States
• Alcon Investigative Site — New York, New York, United States
• Alcon Investigative Site — Poughkeepsie, New York, United States
• Alcon Investigative Site — Elizabeth City, North Carolina, United States
• Alcon Investigative Site — Southern Pines, North Carolina, United States
• Alcon Investigative Site — Florence, South Carolina, United States
• Alcon Investigative Site — Ladson, South Carolina, United States
• Alcon Investigative Site — Austin, Texas, United States
• Alcon Investigative Site — Nacogdoches, Texas, United States
• Alcon Investigative Site — Appleton, Wisconsin, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.